Search Results 1871-1880 of 16111 for first%20aide%20basic

1. AMT-260 Gene Therapy Study in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

2. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

   ... first two cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics ...

3. Medical Research & Education - Mayo Clinic News Network

   First hybrid gene therapy shows early promise in treating long QT syndrome featured image. Individualized Medicine. First hybrid gene therapy shows early ...

4. Medical Research & Education - Mayo Clinic News Network

   Cancer. Mayo Clinic launches first-in-world mate-pair sequencing test that locates “breakpoints” of chromosome rearrangements. Gina Chiri-Osmond. May 10, 2017.

5. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

   A first degree relative with NF1. A PN is defined as a neurofibroma that has grown along the length of a nerve and may involve multiple fascicles and ...

6. A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... first study treatment. Patients must have achieved MR or better to at least ...

7. A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome - Mayo Clinic

   A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome · Overview.

8. A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

9. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

   ... first year of onset, as well as no evidence of other diseases that could explain these features. Probable PSP requires vertical supranuclear gaze palsy ...

10. Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML - Mayo Clinic

    first early relapse after a remission duration of fewer than 6 months; or; relapse refractory to salvage combination therapy; or; second or subsequent relapse ...